Olivia Uitto

Olivia Uitto

Goodwin

Contact
View Bio
RSS

Latest Posts › Marketing Authorization Application

Share:

Adalimumab biosimilar wins NMPA approval

Shanghai Junshi Biosciences Co. Ltd. and Mabwell Bioscience Co. Ltd. announced that the jointly developed adalimumab biosimilar injection (Junmaikang ®) was officially approved by the Chinese National Medical Products...more

3/9/2022  /  Biosimilars , China , Marketing Authorization Application , Pharmaceutical Industry , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide